Scott W. Woods
University of California, San Francisco
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Scott W. Woods.
Schizophrenia Research | 2018
B.B. Brodey; R.R. Girgis; O.V. Favorov; Jean Addington; Diana O. Perkins; Carrie E. Bearden; Scott W. Woods; Elaine F. Walker; Barbara A. Cornblatt; G. Brucato; B. Walsh; K.A. Elkin; I.S. Brodey
Machine learning techniques were used to identify highly informative early psychosis self-report items and to validate an early psychosis screener (EPS) against the Structured Interview for Psychosis-risk Syndromes (SIPS). The Prodromal Questionnaire-Brief Version (PQ-B) and 148 additional items were administered to 229 individuals being screened with the SIPS at 7 North American Prodrome Longitudinal Study sites and at Columbia University. Fifty individuals were found to have SIPS scores of 0, 1, or 2, making them clinically low risk (CLR) controls; 144 were classified as clinically high risk (CHR) (SIPS 3-5) and 35 were found to have first episode psychosis (FEP) (SIPS 6). Spectral clustering analysis, performed on 124 of the items, yielded two cohesive item groups, the first mostly related to psychosis and mania, the second mostly related to depression, anxiety, and social and general work/school functioning. Items within each group were sorted according to their usefulness in distinguishing between CLR and CHR individuals using the Minimum Redundancy Maximum Relevance procedure. A receiver operating characteristic area under the curve (AUC) analysis indicated that maximal differentiation of CLR and CHR participants was achieved with a 26-item solution (AUC=0.899±0.001). The EPS-26 outperformed the PQ-B (AUC=0.834±0.001). For screening purposes, the self-report EPS-26 appeared to differentiate individuals who are either CLR or CHR approximately as well as the clinician-administered SIPS. The EPS-26 may prove useful as a self-report screener and may lead to a decrease in the duration of untreated psychosis. A validation of the EPS-26 against actual conversion is underway.
Archive | 2010
Thomas H. McGlashan; Barbara Walsh; Scott W. Woods
Schizophrenia Research | 2012
Jean Addington; Kristin S. Cadenhead; Barbara A. Cornblatt; Daniel H. Mathalon; Thomas H. McGlashan; Diana O. Perkins; Larry J. Seidman; Ming T. Tsuang; Elaine F. Walker; Scott W. Woods; Jack A. Addington; Tyrone D. Cannon
Schizophrenia Research | 2003
T.H. McGlashan; Robert B. Zipursky; Diana O. Perkins; Jean Addington; Scott W. Woods; Tandy J. Miller; Stacy R. Lindborg; E. Marquez; Keith A. Hawkins; Ralph E. Hoffman; Mauricio Tohen; Alan Breier
Schizophrenia Research | 2003
Scott W. Woods; Alan Breier; Robert B. Zipursky; Diana O. Perkins; Jean Addington; Tandy J. Miller; Keith A. Hawkins; E. Marquez; Stacy R. Lindborg; Mauricio Tohen; T.H. McGlashan
Schizophrenia Research | 2008
Barbara A. Cornblatt; Jean Addington; Larry J. Seidman; Elaine F. Walker; Kristin S. Cadenhead; Tyrone D. Cannon; T.H. McGlashan; Diana O. Perkins; Scott W. Woods; Robert Heinssen
Archive | 2015
Clark Jeffries; Diana O. Perkins; Elaine F. Walker; Tyrone D. Cannon; Thomas H. McGlashan; Scott W. Woods; Barbara A. Cornblatt; Larry J. Seidman; Kristin S. Cadenhead; Ming T. Tsuang; David Mathalon; Carrie E. Bearden; Jean Addington
Archive | 2012
Thomas H. McGlashan; Adrian Preda; Alan Breier; Jill Glist; Jean Addington; Diana O. Perkins; Ralph E. Hoffman; Scott W. Woods; Keith A. Hawkins; Brian Pittman
Archive | 2011
Thomas H. McGlashan; Barbara Walsh; Scott W. Woods; 雅文 水野; 啓之 小林
Archive | 2011
Jean Addington; Barbara A. Cornblatt; Kristin S. Cadenhead; Tyrone D. Cannon; Thomas H. McGlashan; Diana O. Perkins; Larry J. Seidman; Ming T. Tsuang; Elaine F. Walker; Scott W. Woods; Robert Heinssen